Coronary Artery Restenosis
10 clinical trials · Condition
◉ Watch Coronary Artery Restenosis
| Record | Firm | Date |
|---|---|---|
| ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients. (NCT01759290) | Abbott Medical Devices | 2013-01-01 |
| XIENCE V: SPIRIT WOMEN Sub-study (NCT01182428) | Abbott Medical Devices | 2008-09-01 |
| EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (NCT01310309) | Abbott Medical Devices | 2007-09-01 |
| EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (NCT00531011) | Abbott Medical Devices | 2007-09-01 |
| XIENCE V: SPIRIT WOMEN (NCT00496938) | Abbott Medical Devices | 2007-07-01 |
| SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) (NCT00180479) | Abbott Medical Devices | 2005-06-01 |
Track Coronary Artery Restenosis automatically
Every clearance here is in the API, with alerts when new ones post.